Pharmaceutical Giants Gear Up for Second Wave of Lawsuits Over Medicare Pricing Negotiations
Major pharmaceutical companies are preparing for a second wave of lawsuits against the Biden administration’s Medicare drug pricing negotiation process, according to Pharmaceutical Research and Manufacturers of America (PhRMA) CEO, Stephen Ubl. His remarks to Bloomberg Law signaled that the industry is bracing for what could be an extended legal battle. The Health and Human…